Login to Your Account

GSK Offering $1.4B To Buy ID Biomedical, Flu Vaccine

By Karen Pihl-Carey

Thursday, September 8, 2005
In what could be the largest vaccine transaction in history, GlaxoSmithKline plc offered to acquire ID Biomedical for $1.4 billion. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription